DCM
EDIT icon

Dupont Capital Management’s Editas Medicine EDIT Stock Holding History

Dupont Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,040
Closed -$98K – 1457
2022
Q3 		$98K Sell
8,040
-13,987
-63% -$218K 0.01% 1046
2022
Q2 		$261K Hold
22,027
– – 0.01% 889
2022
Q1 		$419K Buy
22,027
+15,965
+263% +$297K 0.02% 839
2021
Q4 		$161K Sell
6,062
-2,417
-29% -$83.2K 0.01% 1187
2021
Q3 		$348K Sell
8,479
-1,199
-12% -$65.7K 0.01% 1029
2021
Q2 		$548K Hold
9,678
– – 0.01% 918
2021
Q1 		$406K Sell
9,678
-1,985
-17% -$113K 0.01% 1031
2020
Q4 		$818K Sell
11,663
-871
-7% -$35.8K 0.02% 640
2020
Q3 		$352K Buy
12,534
+2,210
+21% +$72K 0.01% 916
2020
Q2 		$305K Sell
10,324
-922
-8% -$24.1K 0.01% 965
2020
Q1 		$223K Sell
11,246
-2,202
-16% -$55.5K 0.01% 979
2019
Q4 		$398K Hold
13,448
– – 0.01% 946
2019
Q3 		$306K Sell
13,448
-1,442
-10% -$35.7K 0.01% 984
2019
Q2 		$368K Buy
+14,890
New +$355K 0.01% 915
2018
Q3 		– Sell
-9,551
Closed -$342K – 983
2018
Q2 		$342K Buy
+9,551
New +$338K 0.01% 797

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Dupont Capital Management's EDIT Position: Q4 2022 in Review

Dupont Capital Management sold out of Editas Medicine (EDIT) in Q4 2022, closing a stake of 8,040 shares — an estimated $98K sold.

Dupont Capital Management first reported a position in EDIT in Q2 2018 and held it in 15 quarters. The position peaked at $818K in Q4 2020. 250 funds tracked by Wall St. Rank hold EDIT as of Q4 2022.

  • Dupont Capital Management reported no remaining Editas Medicine position as of Q4 2022 after selling out during the quarter.
  • Dupont Capital Management sold 8,040 Editas Medicine shares in Q4 2022, an estimated $98K.
  • Dupont Capital Management first reported a position in Editas Medicine in Q2 2018 and held it in 15 quarters.
  • Dupont Capital Management's Editas Medicine position peaked at $818K in Q4 2020.
  • 250 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2022.

Based on Dupont Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.